Estrella Immunopharma, Inc.
ESLA
$0.97
$0.00050.05%
NASDAQ
| 06/30/2025 | 03/31/2025 | 09/30/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.54M | -2.10M | -3.38M | -3.38M | -3.95M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 159.10K | 159.10K | -- | -- | -- |
| Change in Net Operating Assets | 4.97M | 1.48M | 1.16M | 1.16M | 3.66M |
| Cash from Operations | -414.90K | -466.00K | -2.22M | -2.22M | -291.50K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.35M | -- | -- | -- | -- |
| Repurchase of Common Stock | 0.00 | -29.50K | -150.50K | -150.50K | -270.30K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -40.00K | -- | -- | -- | -- |
| Cash from Financing | 1.31M | -29.50K | -150.50K | -150.50K | -270.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 895.10K | -495.40K | -2.37M | -2.37M | -561.90K |